AUM $10.30BER 0.44%NAV $202.67Holdings 244Inception Feb 2001
Price Chart
Key Statistics
Previous Close
$202.64Day Range
$202.75$205.31
52-Week Range
$139.07$216.96
Avg Volume
1.5MDividend Yield
0.23%Expense Ratio
0.44%AUM
$10.30BShares Outstanding
49.4METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 85.49% |
| Netherlands | 4.19% |
| Denmark | 2.41% |
| Switzerland | 2.38% |
| United Kingdom | 1.69% |
| Other | 0.71% |
| Canada | 0.70% |
| Germany | 0.67% |
| Ireland | 0.66% |
| France | 0.53% |
| China | 0.17% |
| Spain | 0.12% |
| Australia | 0.09% |
| Belgium | 0.08% |
| Italy | 0.07% |
| Luxembourg | 0.05% |
| Taiwan | 0.00% |
Fund Information
- Issuer
- iShares
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Feb 5, 2001
- Exchange
- NASDAQ
- Description
- The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Similar ETFs
The iShares Biotechnology ETF (IBB) is an exchange-traded fund issued by iShares that launched on Feb 5, 2001. It currently manages $10.30B in assets under management. The fund charges an expense ratio of 0.44%. The fund holds 244 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 47.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS | 7.94% | 1,589,681 | $828.4M |
| 2 | AMGN | AMGEN INC | 7.92% | 2,112,427 | $826.5M |
| 3 | GILD | GILEAD SCIENCES | 7.38% | 5,292,309 | $770.8M |
| 4 | REGN | REGENERON PHARMACEUTICALS | 5.95% | 768,932 | $621.0M |
| 5 | ARGX | ARGENX SE ADR | 3.80% | 395,921 | $396.8M |
| 6 | MRNA | MODERNA | 3.60% | 2,768,685 | $375.5M |
| 7 | NTRA | NATERA | 3.29% | 1,040,590 | $343.7M |
| 8 | RVMD | REVOLUTION MEDICINES | 2.89% | 1,450,765 | $301.3M |
| 9 | ALNY | ALNYLAM PHARMACEUTICALS | 2.50% | 1,013,147 | $261.4M |
| 10 | ILMN | ILLUMINA INC | 2.26% | 1,149,918 | $235.7M |
| 11 | BIIB | BIOGEN | 2.25% | 1,115,305 | $235.0M |
| 12 | ONC | BEONE MEDICINES AG | 2.04% | 606,689 | $212.9M |
| 13 | INSM | INSMED | 2.02% | 1,635,941 | $210.7M |
| 14 | INCY | INCYTE CORP | 1.82% | 1,508,307 | $190.1M |
| 15 | ROIV | ROIVANT SCIENCES LTD | 1.58% | 3,934,360 | $164.5M |
Page 1 of 5
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.40% | |
| 1W | -4.24% | |
| 1M | +2.01% | |
| 3M | +17.87% | |
| 6M | +21.41% | |
| YTD | +20.08% | |
| 1Y | +43.94% | |
| 3Y | +59.66% | |
| 5Y | +19.42% |
Moving Averages
20-Day MA
$209.54
Below 20-Day MA50-Day MA
$199.10
Above 50-Day MA200-Day MA
$178.18
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$216.96
Current Price
$203.50
52-Week Low
$139.07
$139.07$216.96
Current Yield
0.23%
Annual Dividend
$0.4505
Frequency
Quarterlyx/year
Last Ex-Date
Jun 15, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Jun 15, 2026 | $0.0238 | Jun 18, 2026 |
| Mar 17, 2026 | $0.1218 | Mar 20, 2026 |
| Mar 17, 2026 | $0.1218 | Mar 20, 2026 |
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Sep 16, 2025 | $0.0828 | Sep 19, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1240 | Dec 27, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Jun 7, 2023 | $0.0062 | Jun 13, 2023 |
| Mar 23, 2023 | $0.0646 | Mar 29, 2023 |
| Dec 13, 2022 | $0.1014 | Dec 19, 2022 |
| Dec 13, 2022 | $0.1010 | Dec 19, 2022 |
Dividend Payments Over Time
Category Comparison
| Metric | IBB | Healthcare(254 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.44% | 0.62% | 0.85% |
| AUM | $10.30B | $1.73B | $1.80B |
| Dividend Yield | 0.23% | 3.97% | 1.97% |
| Avg Volume | 1.5M | 364.4K | 1.1M |
| Holdings | 244 | 160 | 63 |
| Performance | |||
| 1-Month Return | +2.36% | -2.86% | -0.76% |
| 6-Month Return | +16.63% | +7.23% | +15.71% |
| YTD Return | +20.24% | +10.59% | +18.57% |
| 1-Year Return | +20.71% | +8.50% | +16.28% |
Compare with Another ETF
Search for an ETF to compare with IBB:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.